ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

53,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 127

$7.54M Total Retail Price of All Prescriptions

Rank: 1 out of 127

1,280 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,280 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 6,977 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$140 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
NAMENDA 4,361 800 10 1 15
FAZACLO 2,908 175 10 2 28
CITALOPRAM HBR 2,421 255 10 3 3
ESCITALOPRAM OXALATE 2,290 345 10 4 18
LAMOTRIGINE 2,127 196 10 5 5
CLOZAPINE 2,004 220 10 6 25
DIVALPROEX SODIUM ER 1,328 81 10 7 21
OLANZAPINE 1,174 99 10 8 13
RISPERIDONE 1,134 76 9 2
ABILIFY 1,081 79 10 10 7
POLYETHYLENE GLYCOL 3350 1,008 57 11 48
TOPIRAMATE 969 13 10 12 32
LEVETIRACETAM 898 53 13 52
LITHIUM CARBONATE 867 0 10 14 23
QUETIAPINE FUMARATE 828 118 15 9
OMEPRAZOLE 766 88 16 47
SERTRALINE HCL 749 69 17 6
DONEPEZIL HCL 740 360 18 39
MIRTAZAPINE 735 196 19 11
PINDOLOL 732 11 10 20 56
SEROQUEL XR 688 119 21 27
DIVALPROEX SODIUM 684 126 22 24
LEXAPRO 673 66 10 23 53
BUPROPION XL 667 26 24 19
LEVOTHYROXINE SODIUM 606 106 25 43
TRAZODONE HCL 590 80 26 1
CLONIDINE HCL 575 50 27 44
LISINOPRIL 562 171 28 49
OXCARBAZEPINE 550 0 10 29 31
NALTREXONE HCL 540 11 10 30 61
POTASSIUM CHLORIDE 505 132 31 64
GABAPENTIN 476 170 32 16
SIMVASTATIN 465 91 33 55
FLOVENT HFA 454 0 10 34 69
LACTULOSE 436 18 35 72
NEXIUM 400 19 36 75
METFORMIN HCL 384 64 37 58
ZIPRASIDONE HCL 343 33 38 30
DESMOPRESSIN ACETATE 332 0 10 39 78
IBUPROFEN 329 39 40 74
ZYPREXA 308 16 10 41 71
FUROSEMIDE 301 123 42 67
MINOCYCLINE HCL 299 16 10 43 82
SEROQUEL 288 54 44 33
PRENATAL PLUS 283 0 10 45 84
GUANFACINE HCL 274 0 R 10 46 66
PANTOPRAZOLE SODIUM 257 77 47 88
INVEGA 255 0 10 48 46
RANITIDINE HCL 242 0 49 91
ATORVASTATIN CALCIUM 237 37 50 80
FAMOTIDINE 231 54 51 92
PAROXETINE HCL 230 0 52 22
NAPROXEN 226 74 53 93
NUEDEXTA 225 27 10 54 94
METOPROLOL TARTRATE 218 67 55 81
FLUTICASONE PROPIONATE 209 12 56 99
CYMBALTA 205 0 57 8
MEDROXYPROGESTERONE ACETATE 205 0 10 57 100
EXELON 204 129 59 72
HALOPERIDOL 200 0 60 34
DOXAZOSIN MESYLATE 199 11 61 101
TRAMADOL HCL 194 81 62 57
FLUOXETINE HCL 192 15 63 10
LATUDA 188 0 64 51
CARBAMAZEPINE 184 0 65 45
SUCRALFATE 183 23 66 104
AMANTADINE 179 28 67 63
GEODON 179 16 10 67 68
FANAPT 174 0 10 69 62
AMLODIPINE BESYLATE 170 84 70 105
PROPRANOLOL HCL 169 0 71 36
CALCIUM ACETATE 163 0 72 106
HYDROCHLOROTHIAZIDE 155 23 73 83
TRICOR 153 28 74 107
VALPROIC ACID 148 0 75 59
LOVAZA 146 0 76 109
BUSPIRONE HCL 141 13 77 20
ATENOLOL 129 22 78 113
LIPITOR 120 0 79 115
MELOXICAM 120 39 79 77
METOPROLOL SUCCINATE 120 64 79 115
INVEGA SUSTENNA 112 41 82 38
BENZTROPINE MESYLATE 106 0 R 83 12
MEGESTROL ACETATE 100 56 R 84 118
CRESTOR 94 0 85 119
GEMFIBROZIL 94 12 85 119
ADVAIR DISKUS 88 17 87 121
VENLAFAXINE HCL ER 84 0 88 17
DETROL LA 83 0 89 124
TAMSULOSIN HCL 81 12 90 125
LYRICA 80 0 91 126
MUPIROCIN 80 0 91 126
CLOZAPINE ODT 76 0 10 93 129
OLANZAPINE ODT 76 0 93 95
SPIRIVA 75 22 95 131
NABUMETONE 75 0 95 131
AMITIZA 74 0 97 133
LEVOCETIRIZINE DIHYDROCHLORIDE 71 0 98 135
BUPROPION HCL SR 69 0 99 26
BACLOFEN 68 0 100 138
SYMBICORT 64 13 101 139
BUPROPION HCL 63 18 102 98
GLYBURIDE 60 20 R 103 142
OXYBUTYNIN CHLORIDE ER 59 11 104 143
LANTUS 56 12 105 144
OXYBUTYNIN CHLORIDE 55 12 106 145
CHLORHEXIDINE GLUCONATE 55 12 106 145
CARVEDILOL 54 33 108 147
ZETIA 53 0 109 148
LOSARTAN POTASSIUM 53 0 109 148
SPIRONOLACTONE 53 17 109 148
PROAIR HFA 53 0 109 148
CELEBREX 52 0 113 153
VIMPAT 52 0 113 153
KLOR-CON 10 51 15 115 157
ZOLPIDEM TARTRATE 50 0 116 4
ACETYLCYSTEINE 50 0 116 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.